Quantcast

The Scripps Research Institute has been awarded a $2.35 million grant from the National Institutes of Health to study a new way of treating obesity as part of a national consortium with the Dana-Farber Cancer Institute.

The long-term aim of the research is to develop compounds that can control the formation and function of a particular type of fat cell that burns calories and reduces weight.

Patrick R. Griffin, chair of the Department of Molecular Therapeutics and director of the Translational Research Institute at Scripps Florida, and Theodore Kamenecka, associate scientific director of the Translational Research Institute, are consortium principal investigators, along with Bruce M. Spiegelman, of the Boston-based Dana-Farber Cancer Institute and Harvard Medical School.

The total for the three-year award, a highly competitive National Institutes of Health Director’s Opportunity Grant, is $4.2 million with $2.35 million going to Scripps Research in Florida.

Leave a Reply

Your email address will not be published. Required fields are marked *

*